Use of bisquinoline compounds in the treatment of cerebral disorders

US5756517A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Rudolf Schohe-Loop · Wuppertal, DE
• Peter-Rudolf Seidel · Cologne, DE
• William Bullock · Wuppertal, DE
• Achim Feurer · Wilhelmsfeld, DE
• Georg Terstappen · Düsseldorf, DE
• Joachim Schuhmacher · Wuppertal, DE
• Franz-Josef van der Staay · Dronten, NL
• Bernard Schmidt · Lindlar, DE
• Richard J. Fanelli · Madison, US
• Jane C. Chisholm · Clinton, US
• Richard T. McCarthy · Madison, US

Key dates

• Filing date: Oct 25, 1996
• Grant date: May 26, 1998
• Expiry date: Oct 25, 2016

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D215/46
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of bisquinolines of the general formula ##STR1## in which the substituents mentioned have the meanings given in the description. The invention furthermore relates to new bisquinolines of the general formula (I), to a process for the preparation of the known and the new bisquinolines, to the use of the new bisquinolines as medicaments, to their use for the preparation of medicaments, and to medicaments comprising them.